Friday, October 10, 2025

IRFC board to consider second interim dividend on March 17

Date:

Indian Railway Finance Corporation (IRFC) Ltd has scheduled a board meeting on Monday, March 17, 2025, to consider the declaration of a second interim dividend for the financial year 2024-25.The company has also set March 21, 2025, as the record date to determine shareholders eligible for the dividend, subject to the board’s approval.
For the third quarter, IRFC’s revenue stood at ₹6,763 crore, which is nearly the same level as compared to the ₹6,737 crore topline it had reported during the same quarter last year. Net profit for the period increased by 2% from last year to ₹1,630 crore.
Also Read: PSU Stock Update: Meet the two new ‘Navratna’ companies of IndiaIRFC, the railway financier, also falls into the list of those stocks in which the government could potentially sell a stake to comply with the Minimum Public Shareholding (MPS) norms.

The government continues to remain the largest shareholder in IRFC, with its stake remaining at 86.36%. IRFC is one of the many PSUs where government shareholding continues to remain above 75%, which is the norm for promoters to comply with to achieve minimum public shareholding.

On Thursday (March 13), shares of Indian Railway Finance Corp Ltd ended at ₹117.70, down by ₹1.45, or 1.22%, on the BSE.

Also Read: IRFC shares are down over 50% from their peak; check latest price targets

Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

Bond coupon rate: What is it and why is it crucial for steady income and portfolio stability? Explained

जब आप बांड में निवेश करने का निर्णय लेते...

JNK India wins ₹1,000+ crore ultra-mega contract from Korean promoter JNK Global

Heating equipment maker JNK India Limited on Monday (October...

As Venezuela’s Maria Corina Machado wins Nobel Peace Prize, does Donald Trump still stand a chance

The Norwegian Nobel Committee has awarded the 2025 Nobel...

Zydus Lifesciences wins USFDA nod for deflazacort suspension to treat DMD in children

Drugmaker Zydus Lifesciences Ltd on Monday (October 6) said...